Log In
Print this Print this

TAR-302 (formerly TD-302)

  Manage Alerts
Collapse Summary General Information
Company Taris Biomedical LLC
DescriptionDrug-device combination using the Taris system to deliver a controlled release dosage of an undisclosed drug
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentPreclinical
Standard IndicationIncontinence
Indication DetailsTreat idiopathic overactive bladder (OAB); Treat neurogenic detrusor overactivity (NDO)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today